<?xml version="1.0" encoding="UTF-8"?>
<p id="p0040">SARS-CoV, MERS-CoV, and SARS-CoV-2 have strong human-to-human characteristics, which is attributed to the interaction between S protein and host cell surface receptors. SARS-CoV and SARS-CoV-2 use the angiotensin-converting enzyme 2 (ACE2) as a receptor
 <xref rid="bib15" ref-type="bibr">
  <sup>15</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib16" ref-type="bibr">
  <sup>16</sup>
 </xref>, whereas MERS-CoV uses dipeptidyl peptidase 4 (DPP4; also known as CD26) as a receptor
 <xref rid="bib17" ref-type="bibr">
  <sup>17</sup>
 </xref>. The distribution of receptors in humans and their affinity with S proteins determine the extent of tissue tropism and the intensity of transmission of coronavirus. The epidemiology and biological characteristics of SARS-CoV, MERS-CoV and SARS-CoV-2 are summarized in 
 <xref rid="tbl1" ref-type="table">Table 1</xref>
 <xref rid="bib2" ref-type="bibr">2</xref>, 
 <xref rid="bib3" ref-type="bibr">3</xref>, 
 <xref rid="bib4" ref-type="bibr">4</xref>, 
 <xref rid="bib5" ref-type="bibr">5</xref>, 
 <xref rid="bib6" ref-type="bibr">6</xref>, 
 <xref rid="bib7" ref-type="bibr">7</xref>, 
 <xref rid="bib8" ref-type="bibr">8</xref>
 <sup>,</sup>
 <xref rid="bib12" ref-type="bibr">
  <sup>12</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib15" ref-type="bibr">15</xref>, 
 <xref rid="bib16" ref-type="bibr">16</xref>, 
 <xref rid="bib17" ref-type="bibr">17</xref>.
</p>
